UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           Washington, D. C. 20549
                                 FORM 10-QSB/A


(x)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
     EXCHANGE ACT OF 1934

For the quarterly period ended   September  30,  2001
                                -----------------------

( )  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
     EXCHANGE ACT OF 1934


For the transition period from______________________ to _________________.

Commission File number    000-29057
                       ------------------

                         ALTRIMEGA HEALTH CORPORATION
              -------------------------------------------------
              (Exact name of registrant as specified in charter)

        Nevada                                            87-0631750
 ------------------------------                        ----------------
(State or other jurisdiction of                       (I.R.S. Employer
incorporation or organization)                        Identification No.)


5600 Bell Street, Suite 111, Amarillo, Texas                 79106
---------------------------------------------------        ---------
(Address of principal executive offices)                   (Zip Code)

                                (604) 331-6398
              -------------------------------------------------
              Registrant's telephone number, including area code

            3672 East Cove Point Drive, Salt Lake City, Utah 84109
              -------------------------------------------------
            (Former name, former address, and former fiscal year,
                        if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports),  Yes [x ]  No [ ] and (2) has
been subject to such filing requirements for the past 90 days. Yes [x]  No [ ]

                    APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date

                  Class              Outstanding as of September 30, 2001
           Common Stock, $0.001                 22,020,000





<PAGE> 2
                                    INDEX

                                                                     Page
                                                                     Number
                                                                     --------
PART I.

    ITEM 1.  Financial Statements (unaudited).............................3

             Balance Sheets...............................................4
             September 30, 2001 and December 31, 2000

             Statements of Operations
             Three and nine months ended September 30, 2001 and2000.......5
             and the period September 8, 1998 to September 30, 2001

             Statements of Cash Flows
             Nine months ended September 30, 2001 and 2000................6
             and the period September 8, 1998 to September 30, 2001

             Notes to Financial Statements................................7

    ITEM 2.  Management's Discussion and Analysis or Plan of Operations...9

PART II.     Other Information...........................................10

             Signatures..................................................10










<PAGE>
<PAGE> 3


PART I - FINANCIAL INFORMATION

______________________________________________________________________________

ITEM 1. FINANCIAL STATEMENTS
_____________________________________________________________________________

The accompanying balance sheets of Altrimega Health Corporation (development
stage company) at September 30, 2001 and December 31, 2000, and the statements
of operations and cash flows for the three and nine months ended September 30,
2001 and 2000 and the period from September 8, 1998 to September 30, 2001,
have been prepared by the Company's management and they do not include all
information and notes to the financial statements necessary for a complete
presentation of the financial position, results of operations, cash flows, and
stockholders' equity in conformity with generally accepted accounting
principles.  In the opinion of management, all adjustments considered
necessary for a fair presentation of the results of operations and financial
position have been included and all such adjustments are of a normal recurring
nature.

Operating results for the quarter ended September 30, 2001, are not
necessarily indicative of the results that can be expected for the year ending
December 31, 2001.














<PAGE>
<PAGE> 4



                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                                BALANCE SHEETS
                   September 30, 2001 and December 31, 2000

==============================================================================

                                                   Sept 30,      Dec 31,
                                                   2001          2000
                                                   ------------- -------------
ASSETS
CURRENT ASSETS
 Cash                                              $        108  $         33
                                                   ------------- -------------
   Total Current Assets                                     108            33
                                                   ------------- -------------

PROPERTY AND EQUIPMENT - net of accumulated               1,646         2,066
   depreciation - note 2                           ------------- -------------

                                                   $      1,754  $      2,099
                                                   ============= =============

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Account payable - related party - Note 3         $     37,663  $      5,400
  Accounts payable                                            -         1,500
                                                   ------------- -------------
   Total Current Liabilities                             37,663         6,900
                                                   ------------- -------------

STOCKHOLDERS' EQUITY
  Preferred stock
    10,000,000 shares authorized at $0.001
    par value; none outstanding                               -             -
  Common stock
    50,000,000 shares authorized at $0.001
    par value; 22,020,000 shares issued and
    outstanding                                          22,020        22,020
  Capital in excess of par value                         79,472        74,980
  Deficit accumulated during the development stage     (137,401)     (101,801)
                                                   ------------- -------------

   Total Stockholders' Deficiency                       (35,909)       (4,801)
                                                   ------------- -------------

                                                   $      1,754  $      2,099
                                                   ============= =============



  The accompanying notes are an integral part of these financial statements.


<PAGE>
<PAGE> 5
<TABLE>
<CAPTION>
                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENTS OF OPERATIONS
   For the Three and Nine Months Ended September 30, 2001 and 2000 and the
      Period September 8, 1998 (Date of Inception) to September 30, 2001

==============================================================================


                            Three Months              Nine Months         Sept 8, 1998
                       Sept 30,      Sept 30,     Sept 30,     Sept 30,   to Sept 30,
                        2001          2000          2001        2000      2001
                     ------------ ------------- ------------ ------------ ------------
<S>                  <C>          <C>           <C>          <C>          <C>
REVENUES             $         -  $          -  $         -  $     6,315   $    6,315

EXPENSES                  22,770           222       35,600       65,354      143,716
                     ------------ ------------- ------------ ------------ ------------
NET LOSS             $   (22,770) $       (222) $   (35,600) $   (59,039)  $ (137,401)
                     ============ ============= ============ ============ ============
NET LOSS PER
 COMMON SHARE

 Basic               $         -  $          -  $         -  $         -
                     ============ ============= ============ ============
AVERAGE
 OUTSTANDING SHARES

 Basic (stated
  in 1000's)              22,020        22,020       22,020       22,020
                     ============ ============= ============ ============





  The accompanying notes are an integral part of these financial statements


</TABLE>

<PAGE>
<PAGE> 6
<TABLE>
<CAPTION>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENT OF CASH FLOWS
            For the Nine Months Ended September 30, 2001 and 2000
  and the Period September 8, 1998 (Date of Inception) to September 30, 2001

=============================================================================




                                                                         Sept 8, 1998
                                                 Sept 30     Sept 30     to Sept 30,
                                                  2001         2000      2001
                                             ------------- ------------- -------------
<S>                                          <C>           <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES

Net loss                                     $    (35,600) $    (59,039) $   (137,401)

  Adjustments to reconcile net loss to
  net cash provided by operating activities

     Depreciation and amortization                    420         6,966         1,154
     Changes in accounts payable                   30,763        (1,500)       37,663
     Contributions of capital - expenses              700             -           700
                                             ------------- ------------- -------------

     Net Cash Received (Used) in Operations        (3,717)      (53,573)      (97,884)
                                             ------------- ------------- -------------


CASH FLOWS FROM INVESTING ACTIVITIES

  Purchase of equipment                                 -             -        (2,800)
                                             ------------- ------------- -------------

CASH FLOWS FROM FINANCING ACTIVITIES

  Proceeds from contributions to
   capital - related party                          3,792             -         3,792
  Proceeds from issuance of common stock                -        50,500        97,000
                                             ------------- ------------- -------------

Net Increase (decrease) in Cash                        75        (3,073)          108

Cash at Beginning of Period                            33         4,125             -
                                             ------------- ------------- -------------

Cash at End of Period                        $        108  $      1,052  $        108
                                             ============= ============= =============



  The accompanying notes are an integral part of these financial statements.



</TABLE>

<PAGE>
<PAGE> 7

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                        NOTES TO FINANCIAL STATEMENTS

=============================================================================
1.   ORGANIZATION

The Company was incorporated under the laws of the State of Nevada on
September 8, 1998 with the name of Mega International Health Corporation with
authorized common stock of 50,000,000 shares with a par value of $0.001 and
preferred stock of 10,000,000 shares with a par value of $0.001. The board of
directors will determine the powers and rights of the preferred stock when it
is issued. On June 23, 1999 the name was changed to Altrimega Health
Corporation. On March 19,2001 the Company completed a forward common stock
split of four shares for each outstanding share.  This report has been
completed showing after stock split shares from inception.

The Company was organized for the purpose of marketing nutritional products
however the Company has not started operations.

The Company is in the development stage.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Methods
--------------------
The Company recognizes income and expenses based on the accrual method of
accounting.

Dividend Policy
-----------------
The Company has not adopted a policy regarding payment of dividends.

Property and Equipment
-----------------------
The equipment consists of office furniture and equipment which is being
depreciated over 5 years.

Income Taxes
-------------
On September 30, 2001 the Company had a net operating loss carryforward of
$137,401. The tax benefit of approximately $41,220 from the loss carry forward
has been fully offset by a valuation reserve because the use of the future tax
benefit is doubtful, since the Company has no operations on which to project
future net profits.

The loss carryover will expire in 2022.

Financial Instruments
-----------------------
The carrying amounts of financial instruments, including cash and accounts
payable, are considered by management to be their estimated fair values.


<PAGE> 8

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Basic and Diluted Net Income (Loss) Per Share
-----------------------------------------------
Basic net income (loss) per share amounts are computed based on the weighted
average number of shares actually outstanding. Diluted net income (loss) per
share amounts are computed using the weighted average number of common shares
and common equivalent shares outstanding as if shares had been issued on the
exercise of the preferred share rights unless the exercise becomes
antidilutive and then only the basic per share amounts are shown in the
report.

Estimates and Assumptions
---------------------------
Management uses estimates and assumptions in preparing financial statements in
accordance with generally accepted accounting principles.  Those estimates and
assumptions affect the reported amounts of the assets and liabilities, the
disclosure of contingent assets and liabilities, and the reported revenues and
expenses.  Actual results could vary from the estimates that were assumed in
preparing these financial statements.

Comprehensive Income
---------------------
The Company has adopted Statement of Financial Accounting Standards No. 130.
The adoption of this standard had no impact on the total stockholder's equity.

Other Recent Accounting Pronouncements
----------------------------------------
The Company does not expect that the adoption of other recent accounting
pronouncements to have any material impact on its financial statements.

3.  RELATED PARTY TRANSACTIONS

70% of the outstanding common stock was issued to related parties.
Advances of $37,663 have been received by the Company from a related party.
There are no terms for the advances made by the related party. The advances
are otherwise payable on demand and the Company has not accrued any interest
expense associated with advances.

4.  GOING CONCERN

The company will need additional working capital to service its debt and for
its future planned activity and continuation of the Company as a going concern
is dependent upon obtaining sufficient working capital to be successful in
that effort and the management of the Company has developed a strategy, which
it believes will accomplish this objective through additional equity funding,
and long term financing, which will enable the Company to operate for the
coming year.


<PAGE>
<PAGE> 9


______________________________________________________________________________

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS
______________________________________________________________________________

Overview
----------
The Company's plan of operation focuses on products which have been designed
as a result of the belief its natural medicines and nutritional supplements
offer a better alternative to traditional nutritional supplements currently
being produced by providing specialized combinations of nutrients. Prior to
the formation of Altrimega Health Corporation, an officer of the Company
completed the development of the Company's initial product line, and has
established relationships with suppliers of the various nutrients comprising
the Altrimega Health products. Additionally, the Company has established a
relationship with a Utah "contract" manufacturer, which will provide the
Company with product manufacturing, bottling and packaging.

The Company is now seeking to establish a distributor network with marketing
firms involved in the nutritional supplement industry throughout the country.
The Company also plans to undertake efforts to market its products through the
internet, various retail markets, including health food stores, and direct
sales through a toll-free number.

Proposed Activities
--------------------
As soon as practicable, the Company plans to complete the manufacturing and
distributing arrangements with selected brokers in the industry, in different
regions of the country. At the same time, the Company will continue with
efforts to directly market its products to other retail markets. To the extent
the Company's funds allow, the Company will develop and market additional
nutritional products, to meet different special health needs and niche
markets.

Liquidity and Capital Resources
---------------------------------

As of September 30, 2001, the Company did not have sufficient assets to pay
its liabilities.

Results of Operations
----------------------
The Company is a development stage company and has had no operations during
the past quarter.

Liquidity and Capital Resources
---------------------------------
The Company will need additional working capital to finance its planned
activity.




<PAGE>
<PAGE> 10

PART II - OTHER INFORMATION


                             PART 2 - SIGNATURES

______________________________________________________________________________

                                  SIGNATURES
______________________________________________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned there unto duly authorized.


                                 Altrimega Health Corporation
                                 [Registrant]

                                 /S/ Kelley Magee, Chief Executive Officer
                                  and Principal Accounting Officer

Dated March 27, 2002